Structure-base design to explore the anticancer efficacy of organometallic Pt(II)- and Au(III)-N-heterocyclic carbene (NHC) complexes
Joydev Dinda,Pooja Das,Sraddhya Roy,Nabanita Chatterjee,Chaitali Das,Raju Biswas
DOI: https://doi.org/10.1039/d4nj02853h
IF: 3.3
2024-08-21
New Journal of Chemistry
Abstract:Cancer is one of the leading public health concerns globally; therefore it is required better drugs for treatment. Several strategies have been taken to improve the success of drug discovery. Our strategy is the exploration of organometallic platinum group metal complexes as potential anticancer drugs. Organometallic complexes bearing N-heterocyclic carbene (NHC) ligands are getting attention for therapeutic purposes. Synthesis, structure, and anticancer activities of platinum(II)- and gold(III)-N-heterocyclic carbene complexes supported by proligand 1-methyl-2-(pyridylmethyl)imidazo[1,5-a]pyridin-4-ylium hexafluorophosphate, (1.HPF6) have been described. Two novel isoelectronic and isostructural complexes, viz. [Pt(1)Cl2](2), [Au(1)Cl2][AuCl4] (3), have been synthesized and characterized by a series of spectroscopic techniques. Finally, the square planar geometry of 3 was established by single crystal X-ray diffraction studies. Interestingly, complex 3 possesses Cl--Cl interactions and this is the first organogold bears the same. Molecular docking analysis revealed the highest free binding energy for complex 3 with Human-DNA Topoisomerase. Finally, invitro anticancer studies on breast cancer cell line, MDA-MB231 revealed Au(III)-NHC complex 3 is more potent than Pt(II)-NHC complex 2. therapeutic purposes. Synthesis, structure, and anticancer activities of platinum(II)- and gold(III)-N-heterocyclic carbene complexes supported by proligand 1-methyl-2-(pyridylmethyl)imidazo[1,5-a]pyridin-4-ylium hexafluorophosphate, (1.HPF6) have been described. Two novel isoelectronic and isostructural complexes, viz. [Pt(1)Cl2](2), [Au(1)Cl2][AuCl4] (3), have been synthesized and characterized by a series of spectroscopic techniques. Finally, the square planar geometry of 3 was established by single crystal X-ray diffraction studies. Interestingly, complex 3 possesses Cl--Cl interactions and this is the first organogold bears the same. Molecular docking analysis revealed the highest free binding energy for complex 3 with Human-DNA Topoisomerase. Finally, invitro anticancer studies on breast cancer cell line, MDA-MB231 revealed Au(III)-NHC complex 3 is more potent than Pt(II)-NHC complex 2.
chemistry, multidisciplinary